Cargando…

A Novel Combined Conjugate Therapeutic Cancer Vaccine, Recombinant EGF-CRM197, in Patients With Advanced Solid Tumors: A Phase I Clinical Study

INTRODUCTION: The therapeutic cancer vaccine recombinant Epidermal Growth Factor (EGF)-CRM197 is a novel combined conjugate EGF with CRM197 as a carrier protein. Immunization with the EGF-CRM197 vaccine can induce high levels of neutralizing anti-EGF antibodies that inhibit EGF/EGFR signaling and th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, An-Wen, Fang, Jue-Min, Ren, Sheng-Xiang, Li, Wei, Wang, Jing, Zhao, Yu, Chen, Guo-You, Xu, Qing, Zhou, Cai-Cun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602890/ https://www.ncbi.nlm.nih.gov/pubmed/34804932 http://dx.doi.org/10.3389/fonc.2021.745699

Ejemplares similares

O:2-CRM(197) Conjugates against Salmonella Paratyphi A
por: Micoli, Francesca, et al.
Publicado: (2012)

Structural and immunological characterization of E. coli derived recombinant CRM(197) protein used as carrier in conjugate vaccines
por: Mishra, Ravi P.N., et al.
Publicado: (2018)

Efficient recovery of recombinant CRM197 expressed as inclusion bodies in E.coli
por: Park, Ah-Reum, et al.
Publicado: (2018)

Production in Escherichia coli of recombinant COVID-19 spike protein fragments fused to CRM197
por: Bellone, Maria Laura, et al.
Publicado: (2021)

Site‐Specific Multi‐Functionalization of the Carrier Protein CRM(197) by Disulfide Rebridging for Conjugate Vaccine Development
por: Trattnig, Nino, et al.
Publicado: (2022)

Investigating the Deoxyribonuclease Activity of CRM197 with Site-Directed Mutagenesis
por: Bravo-Bautista, Nathalie, et al.
Publicado: (2019)

Comparison of Immune Responses to Two Quadrivalent Meningococcal Conjugate Vaccines (CRM197 and Diphtheria Toxoid) in Healthy Adults
por: Kim, Han Wool, et al.
Publicado: (2019)

Targeted CRM197-PEG-PEI/siRNA Complexes for Therapeutic RNAi in Glioblastoma
por: Höbel, Sabrina, et al.
Publicado: (2011)

Short Vi-polysaccharide abrogates T-independent immune response and hyporesponsiveness elicited by long Vi-CRM(197) conjugate vaccine
por: Micoli, Francesca, et al.
Publicado: (2020)

Conjugation with 8-arm PEG and CRM(197) enhances the immunogenicity of SARS-CoV-2 ORF8 protein
por: Tang, Xiaozhao, et al.
Publicado: (2022)

Intracellular trafficking of diphtheria toxin and its mutated form, CRM197, in the endocytic pathway
por: Edis, Bilge Ozerman, et al.
Publicado: (2018)

Monomeric crystal structure of the vaccine carrier protein CRM(197) and implications for vaccine development
por: Gallagher, D. Travis, et al.
Publicado: (2023)

Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide
por: Tobias, Joshua, et al.
Publicado: (2017)

CRM197-conjugated peptides vaccine of HCMV pp65 and gH induce maturation of DC and effective viral-specific T cell responses
por: Zhang, Shuyun, et al.
Publicado: (2023)

Safety, Immunogenicity and Dose Ranging of a New Vi-CRM(197) Conjugate Vaccine against Typhoid Fever: Randomized Clinical Testing in Healthy Adults
por: van Damme, Pierre, et al.
Publicado: (2011)

Molecular modeling provides insights into the loading of sialic acid‐containing antigens onto CRM(197): the role of chain flexibility in conjugation efficiency and glycoconjugate architecture
por: Kuttel, Michelle M., et al.
Publicado: (2021)

Post-marketing safety surveillance for both CRM197 and TT carrier proteins PCV13 in Jiangsu, China
por: Hu, Ran, et al.
Publicado: (2023)

Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo(®)) in the context of treatment and prevention of invasive disease
por: Bröker, Michael, et al.
Publicado: (2011)

Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM(197)-Conjugate Vaccine During Pregnancy
por: Madhi, Shabir A, et al.
Publicado: (2017)

Click chemistry compared to thiol chemistry for the synthesis of site-selective glycoconjugate vaccines using CRM(197) as carrier protein
por: Stefanetti, G., et al.
Publicado: (2020)

Augmenting antibody response to EGF-depleting immunotherapy: Findings from a phase I trial of CIMAvax-EGF in combination with nivolumab in advanced stage NSCLC
por: Evans, Rachel, et al.
Publicado: (2022)

CRM197 reverses paclitaxel resistance by inhibiting the NAC‐1/Gadd45 pathway in paclitaxel‐resistant ovarian cancer cells
por: Tang, Xiao‐han, et al.
Publicado: (2019)

Addition of Lauryldimethylamine N-Oxide (LDAO) to a Copper-Free Click Chemistry Reaction Improves the Conjugation Efficiency of a Cell-Free Generated CRM197 Variant to Clinically Important Streptococcus pneumoniae Serotypes
por: Bautista, Leslie, et al.
Publicado: (2022)

Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites
por: Möginger, Uwe, et al.
Publicado: (2016)

CRM for dummies
por: Helgeson, Lars
Publicado: (2017)

CRM Fundamentals
por: Kostojohn, Scott
Publicado: (2011)

PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma
por: Al-Ghazzawi, Karim, et al.
Publicado: (2023)

Directed and elliptic flow in $^{197}Au+^{197}Au$ at intermediate energies
por: Lukasik, J, et al.
Publicado: (2005)

The Position of EGF Deprivation in the Management of Advanced Non-Small Cell Lung Cancer
por: Crombet Ramos, Tania, et al.
Publicado: (2021)

Purity and Uncertainty Study of CRM Betulin by DSC
por: Zhang, Li, et al.
Publicado: (2020)

CRM para directivos /
por: Anderson, Kristin, 1962-
Publicado: (2003)

CRM Workshop on Moonshine
por: Collective
Publicado: (1999)

SugarCRM for dummies
por: Fredricks, Karen S
Publicado: (2009)

Building on SugarCRM
por: Mertic, John
Publicado: (2011)

DI/CRM Workshop
Publicado: (2000)

Using Microsoft CRM
por: Brown, Laura, et al.
Publicado: (2004)

Social CRM For Dummies
por: Lacy, Kyle
Publicado: (2013)

Surv‐CRM‐12: A Bayesian phase I/II survival CRM for right‐censored toxicity endpoints with competing disease progression
por: Andrillon, Anaïs, et al.
Publicado: (2022)

Transforming traditional CRM into social CRM: An empirical investigation in Iraqi healthcare industry
por: Jalal, Abdullah Nabeel, et al.
Publicado: (2021)

Molecular Pharming of the Recombinant Protein hEGF-hEGF Concatenated with Oleosin Using Transgenic Arabidopsis
por: Qiang, Weidong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_04nsrgkb97gl5hrni6n4vdfqbu